Innovative fixed bed bioreactor platform: Enabling linearly scalable adherent cell biomanufacturing with real‐time biomass prediction from nutrient consumption
Biotechnology Journal · 2024-08 · 19 (8)
DOI: 10.1002/biot.202300635 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology Journal, online erschienen am 21.08.2024. Verfasst von Vasiliy N Goral und 17 weiteren Autor:innen. Beteiligte Einrichtung: Corning Life Sciences, Corning Incorporated, Corning, New York, USA. Hauptthemen laut MEDLINE: Bioreactors, Biomass, Cell Culture Techniques. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Scalable single‐use adherent cell‐based biomanufacturing platforms are essential for unlocking the full potential of cell and gene therapies. The primary objective of this study is to design and develop a novel fixed bed bioreactor platform tailored specifically for scaling up adherent cell culture. The bioreactor comprises a packed bed of vertically stacked woven polyethylene terephthalate mesh discs, sandwiched between two‐fluid guide plates. Leveraging computational fluid dynamics modeling, we optimized bioreactor design to achieve uniform flow with minimal shear stress. Residence time distribution measurements demonstrated excellent flow uniformity with plug flow characteristics. Periodic media sampling coupled with offline analysis revealed minimal gradients of crucial metabolites (glucose, glutamine, lactate, and ammonia) across the bioreactor during cell growth. Furthermore, the bioreactor platform demonstrated high performance in automated cell harvesting, with ≈96% efficiency and ≈98% viability. It also exhibited linear scalability in both operational parameters and performance for cell culture and adeno‐associated virus vector production. We developed mathematical models based on oxygen uptake rates to accurately predict cell growth curves and estimate biomass in real‐time. This study demonstrates the effectiveness of the developed fixed‐bed bioreactor platform in enabling scalable adherent cell‐based biomanufacturing with high productivity and process control.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Corning Life Sciences, Corning Incorporated, Corning, New York, USA.
ORCID-Profile: Ye Fang, Zara Melkoumian
Zitieren
APA
Goral, V. N., Hong, Y., Scibek, J. J., Sun, Y., Romeo, L. E., Rao, A., Manning, D., Zhou, Y., Schultes, J. A., Tjong, V., Pikula, D., Krebs, K. A., Ferrie, A. M., Kramel, S., Weber, J. L., Upton, T. M., Fang, Y., & Melkoumian, Z. (2024). Innovative fixed bed bioreactor platform: Enabling linearly scalable adherent cell biomanufacturing with real‐time biomass prediction from nutrient consumption. Biotechnology Journal, 19(8). https://doi.org/10.1002/biot.202300635
Vancouver
Goral VN, Hong Y, Scibek JJ, Sun Y, Romeo LE, Rao A, et al. Innovative fixed bed bioreactor platform: Enabling linearly scalable adherent cell biomanufacturing with real‐time biomass prediction from nutrient consumption. Biotechnology Journal. 2024;19(8). doi:10.1002/biot.202300635
BibTeX
@article{Goral2024,
author = {Goral, Vasiliy N and Hong, Yulong and Scibek, Jeffery J and Sun, Yujian and Romeo, Lori E and Rao, Abhijit and Manning, Daniel and Zhou, Yue and Schultes, Joel A and Tjong, Vinalia and Pikula, Dragan and Krebs, Kathleen A and Ferrie, Ann M and Kramel, Stefan and Weber, Jennifer L and Upton, Todd M and Fang, Ye and Melkoumian, Zara},
title = {Innovative fixed bed bioreactor platform: Enabling linearly scalable adherent cell biomanufacturing with real‐time biomass prediction from nutrient consumption},
journal = {Biotechnology Journal},
year = {2024},
volume = {19},
number = {8},
doi = {10.1002/biot.202300635}
}
EUVIMED